Hemera Biosciences

Janssens Beerse campus
Biotech

Janssen buys up eye disorder gene therapy asset from Hemera

Janssen is tapping little-known and privately held Hemera Biosciences for a new gene therapy aimed at reversing a severe disease.
Ben Adams Dec 2, 2020 9:15am